Guggenheim Capital’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$314K Sell
4,283
-836
-16% -$61.4K ﹤0.01% 1378
2025
Q1
$585K Sell
5,119
-456
-8% -$52.1K 0.01% 1124
2024
Q4
$281K Buy
+5,575
New +$281K ﹤0.01% 1469
2023
Q4
Sell
-6,540
Closed -$205K 1884
2023
Q3
$205K Sell
6,540
-13,355
-67% -$419K ﹤0.01% 1744
2023
Q2
$443K Sell
19,895
-12,617
-39% -$281K ﹤0.01% 1522
2023
Q1
$704K Buy
32,512
+13,687
+73% +$296K 0.01% 1339
2022
Q4
$382K Sell
18,825
-2,834
-13% -$57.6K ﹤0.01% 1590
2022
Q3
$555K Sell
21,659
-369
-2% -$9.46K 0.01% 1432
2022
Q2
$524K Sell
22,028
-1,948
-8% -$46.3K ﹤0.01% 1560
2022
Q1
$540K Buy
23,976
+2,116
+10% +$47.7K ﹤0.01% 1658
2021
Q4
$433K Sell
21,860
-42,120
-66% -$834K ﹤0.01% 1750
2021
Q3
$1.26M Buy
63,980
+41,331
+182% +$813K 0.01% 1298
2021
Q2
$498K Sell
22,649
-1,521
-6% -$33.4K ﹤0.01% 1830
2021
Q1
$575K Sell
24,170
-21,167
-47% -$504K ﹤0.01% 1656
2020
Q4
$1.19M Buy
45,337
+35,064
+341% +$917K 0.01% 1242
2020
Q3
$179K Sell
10,273
-5,255
-34% -$91.6K ﹤0.01% 1806
2020
Q2
$261K Buy
+15,528
New +$261K ﹤0.01% 1653
2020
Q1
Sell
-17,319
Closed -$210K 1872
2019
Q4
$210K Buy
17,319
+786
+5% +$9.53K ﹤0.01% 1978
2019
Q3
$234K Sell
16,533
-5,170
-24% -$73.2K ﹤0.01% 1952
2019
Q2
$242K Sell
21,703
-12,777
-37% -$142K ﹤0.01% 1959
2019
Q1
$405K Sell
34,480
-13,249
-28% -$156K ﹤0.01% 1784
2018
Q4
$637K Sell
47,729
-59,049
-55% -$788K 0.01% 1569
2018
Q3
$1.5M Buy
106,778
+18,236
+21% +$256K 0.01% 1409
2018
Q2
$1.39M Sell
88,542
-149,909
-63% -$2.36M 0.01% 1452
2018
Q1
$3.92M Buy
238,451
+27,324
+13% +$450K 0.01% 1160
2017
Q4
$3.81M Buy
+211,127
New +$3.81M 0.01% 1193
2017
Q2
Sell
-19,441
Closed -$213K 2835
2017
Q1
$213K Sell
19,441
-7,147
-27% -$78.3K ﹤0.01% 2614
2016
Q4
$193K Sell
26,588
-1,755
-6% -$12.7K ﹤0.01% 2695
2016
Q3
$184K Sell
28,343
-1,448
-5% -$9.4K ﹤0.01% 2673
2016
Q2
$163K Buy
29,791
+1,501
+5% +$8.21K ﹤0.01% 2690
2016
Q1
$132K Buy
+28,290
New +$132K ﹤0.01% 2738